Status:
COMPLETED
Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln in Long-term Survivors of Lymphoma
Lead Sponsor:
University of Bari Aldo Moro
Conditions:
Lymphoma, Hodgkin
Menstrual Irregularity
Eligibility:
FEMALE
25-44 years
Brief Summary
The progressive improvement of lymphoma treatment has led to an important prolongation of patient survival and life expectancy. Therefore, the principal International scientific societies of oncology,...
Detailed Description
Anticancer regimens are usually used to treat patients with lymphoproliferative neoplasms with a consequently transitory or permanent damage to their reproductive functionalities. Rates of gonadotoxic...
Eligibility Criteria
Inclusion
- Patients with Classical Hodgkin lymphoma (cHL) and Diffuse Large B-cell lymphoma (DLBCL) long survival
Exclusion
Key Trial Info
Start Date :
February 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 7 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05410314
Start Date
February 7 2020
End Date
December 7 2021
Last Update
June 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS - Istituto Oncologico"Giovanni PaoloII"
Bari, Italy, 70124